P-224 XPD polymorphisms in cisplatin (cis)/vinorelbine (vrb)-treated stage IV non-small-cell lung cancer (NSCLC) patients (p): genetic analysis of a Spanish Lung Cancer Group phase II trial

Lung Cancer ◽

10.1016/s0169-5002(03)92193-3 ◽

2003 ◽

Vol 41 ◽

pp. S148 ◽

Author(s):

Nuria Vin˜olas ◽

Barbara Roig ◽

Noemi Reguart ◽

Mariano Provencio ◽

Felipe Cardenal ◽

...

Keyword(s):

Lung Cancer ◽

Genetic Analysis ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Stage Iv ◽

Small Cell Lung ◽

Cancer Group ◽

Download Full-text

P-225 XPD and RRM1 gene polymorphisms predict gemcitabine (gem)/cisplatin (cis)/docetaxel (doc) outcome in stage III non-small-cell lung cancer (NSCLC): a genetic analysis of the Spanish Lung Cancer Group phase II trial 9901

Lung Cancer ◽

10.1016/s0169-5002(03)92194-5 ◽

2003 ◽

Vol 41 ◽

pp. S148 ◽

Author(s):

Carme Sarries ◽

Pilar Garrido ◽

Laura Nun˜ez ◽

Barbara Roig ◽

Jose Luis Ramirez ◽

...

Keyword(s):

Lung Cancer ◽

Genetic Analysis ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Gene Polymorphisms ◽

Phase Ii Trial ◽

Small Cell Lung ◽

Download Full-text

P-533 Single agent weekly paclitaxel chemotherapy in elderly or frailnon-small cell lung cancer (NSCLC) patients: Final results of a phase II trial Spanish Lung Cancer Group (GECP 00/02)

Lung Cancer ◽

10.1016/s0169-5002(05)81026-8 ◽

2005 ◽

Vol 49 ◽

pp. S257-S258

Author(s):

B. Massuti ◽

C. Camps ◽

P. Garrido ◽

N. Viñolas ◽

J. Barcelo ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Trial ◽

Single Agent ◽

Small Cell Lung ◽

Cancer Group ◽

Download Full-text

Abstract CT041: Identification of gene signatures associated with response in a Phase II trial of entinostat (ENT) plus pembrolizumab (PEMBRO) in non-small cell lung cancer (NSCLC) patients whose disease has progressed on or after anti-PD-(L)1 therapy

10.1158/1538-7445.am2019-ct041 ◽

2019 ◽

Author(s):

Peter Ordentlich ◽

Lei Wang ◽

David Tamang ◽

Amy H. Sullivan ◽

Sally E. Church ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Trial ◽

Small Cell Lung ◽

Gene Signatures ◽

Download Full-text

Randomised Phase II Trial of Oral Vinorelbine (N) and Cisplatin (P) or Pemetrexed and C (PC) in First Line Advanced Non Squamous (NSCC) Non Small Cell Lung Cancer (NSCLC) Patients (PTS). Navotrial01: Final Results

Annals of Oncology ◽

10.1016/s0923-7534(20)33841-2 ◽

2012 ◽

Vol 23 ◽

pp. ix409

Author(s):

E.H. Tan ◽

L. Havel ◽

M.J. Krzakowski ◽

J. Kollmeier ◽

R. Gervais ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Trial ◽

Small Cell Lung ◽

Oral Vinorelbine ◽

Download Full-text

Phase II trial of Belagenpumatucel-L, a TGF-β2 antisense gene modified allogeneic tumor vaccine in advanced non small cell lung cancer (NSCLC) patients

Cancer Gene Therapy ◽

10.1038/cgt.2009.15 ◽

2009 ◽

Vol 16 (8) ◽

pp. 620-624 ◽

Author(s):

J Nemunaitis ◽

M Nemunaitis ◽

N Senzer ◽

P Snitz ◽

C Bedell ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Trial ◽

Tumor Vaccine ◽

Small Cell Lung ◽

Antisense Gene ◽

Download Full-text

Taxol and carboplatin in combination in stage IV and IIIB non small-cell lung cancer (NSCLC): A phase II trial

Lung Cancer ◽

10.1016/0169-5002(94)94269-2 ◽

1994 ◽

Vol 11 ◽

pp. 129

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Trial ◽

Stage Iv ◽

Small Cell Lung

Download Full-text

Sequential vinorelbine (V) and docetaxel (D) in advanced non-small cell lung cancer (NSCLC) patients age > 70, or with performance status (PS) 2: A SWOG phase II trial (S0027)

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.14_suppl.7056 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 7056-7056 ◽

Author(s):

P. J. Hesketh ◽

K. Chansky ◽

D. H. Lau ◽

J. Crowley ◽

D. R. Gandara

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Trial ◽

Performance Status ◽

Small Cell Lung ◽

Download Full-text

Randomized phase II trial of carboplatin (C) and gemcitabine (G) with or without dexamethasone (Dex) in patients (pts) with stage IV non-small cell lung cancer (NSCLC).

Journal of Clinical Oncology ◽

10.1200/jco.2010.28.15_suppl.9150 ◽

2010 ◽

Vol 28 (15_suppl) ◽

pp. 9150-9150 ◽

Author(s):

J. J. Rinehart ◽

S. M. Arnold ◽

G. H. Kloecker ◽

A. Lim ◽

M. A. Zaydan ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Trial ◽

Stage Iv ◽

Small Cell Lung ◽

Randomized Phase Ii

Download Full-text

Results of a Phase II Trial of Carboplatin, Pemetrexed, and Bevacizumab for the Treatment of Never or Former/Light Smoking Patients With Stage IV Non–Small Cell Lung Cancer

Clinical Lung Cancer ◽

10.1016/j.cllc.2015.12.006 ◽

2016 ◽

Vol 17 (2) ◽

pp. 128-132 ◽

Author(s):

Jared M. Weiss ◽

Liza C. Villaruz ◽

Jonathon O'Brien ◽

Anastasia Ivanova ◽

Carrie Lee ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Trial ◽

Stage Iv ◽

Small Cell Lung ◽

Download Full-text

P-203 SLCG 9901: phase II trial with cisplatin (cis), gemcitabine (gem) and docetaxel (doc) as neoadjuvant treatment in stage IIIA N2 and T4N0-1 non-small cell lung cancer (NSCLC) patients

Lung Cancer ◽

10.1016/s0169-5002(03)92172-6 ◽

2003 ◽

Vol 41 ◽

pp. S142

Author(s):

Pilar Garrido ◽

Ramón Barceló ◽

Angel Artal ◽

Josefa Terrasa ◽

Bartomeu Massuti ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Trial ◽

Neoadjuvant Treatment ◽

Small Cell Lung ◽

Download Full-text